These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tumor immunology. Shehadeh IH J Med Liban; 1972; 25(3):199-203. PubMed ID: 5086706 [No Abstract] [Full Text] [Related]
5. [Immunological problems in oncology]. Gazzera G G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(1):37-80. PubMed ID: 5158566 [No Abstract] [Full Text] [Related]
6. Cellular and humoral immunity in tumour bearing animals immunized with erythrocytes. Donovan G; Dumitrescu R; Popp I; Maltezeanu G Neoplasma; 1971; 18(3):241-9. PubMed ID: 5093945 [No Abstract] [Full Text] [Related]
7. Lipids, immunity and cancer. de Echegaray SD; Santiago Delpín EA; Lavergne J Bol Asoc Med P R; 1982; 74(7-8):231-3. PubMed ID: 6963910 [No Abstract] [Full Text] [Related]
8. [Importance of specific and nonspecific immunity in anti-tumor defense]. Biozzi G; Stiffel C; Mouton D; Bouthillier Y; Decreusefond C Ann Inst Pasteur (Paris); 1972 Apr; 122(4):685-94. PubMed ID: 5050875 [No Abstract] [Full Text] [Related]
9. [Antigenic structure of human and animal tumor cells]. Harlozińska A Postepy Hig Med Dosw; 1971; 25(3):367-89. PubMed ID: 5571143 [No Abstract] [Full Text] [Related]
10. [Cancer and immunity]. Nagel GA; Geiger C Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152 [No Abstract] [Full Text] [Related]
12. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217 [TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in intact C57B1 and C3HA line mice and the dynamics of their changes during tumor growth]. Saraeva ZM; Tereshchenko IP; Kalina MM Patol Fiziol Eksp Ter; 1974; (1):62-5. PubMed ID: 4617853 [No Abstract] [Full Text] [Related]
14. Release of a non-specific cytotoxic factor by splenic cells immunized against allogeneic tumour cells. Hottier D; Donner M; Burg C Rev Eur Etud Clin Biol; 1971 Mar; 16(3):240-3. PubMed ID: 5104840 [No Abstract] [Full Text] [Related]
15. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495 [No Abstract] [Full Text] [Related]
16. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model. Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283 [TBL] [Abstract][Full Text] [Related]
17. [Immunologic exploration of cancer patients. 1. Nontumoral immunity]. Cappelaere P; Adenis L; Demaille A Lille Med; 1973 Jun; 18(1):96-112. PubMed ID: 4352336 [No Abstract] [Full Text] [Related]
18. [NK cells--their role and importance in antitumor resistance]. Mircheva Zh Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848 [No Abstract] [Full Text] [Related]
19. [Role of the spleen in immunological processes]. Robak T; Płuzańska A Postepy Hig Med Dosw; 1980; 33(6):625-41. PubMed ID: 6992130 [No Abstract] [Full Text] [Related]
20. Immunity in malignant disease. Fairley GH Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160 [No Abstract] [Full Text] [Related] [Next] [New Search]